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In vivo assessment of cancer and precise location of altered tissues at initial stages of molecular disorders are im-
portant diagnostic challenges. Positronium is copiously formed in the free molecular spaces in the patient’s body 
during positron emission tomography (PET). The positronium properties vary according to the size of inter- and 
intramolecular voids and the concentration of molecules in them such as, e.g., molecular oxygen, O2; therefore, 
positronium imaging may provide information about disease progression during the initial stages of molecular 
alterations. Current PET systems do not allow acquisition of positronium images. This study presents a new method 
that enables positronium imaging by simultaneous registration of annihilation photons and deexcitation pho-
tons from pharmaceuticals labeled with radionuclides. The first positronium imaging of a phantom built from 
cardiac myxoma and adipose tissue is demonstrated. It is anticipated that positronium imaging will substantially 
enhance the specificity of PET diagnostics.
INTRODUCTION
Personalized treatment, which is aimed at providing tailored medi-
cal treatment for individual patients, requires diagnostic methods 
that have a high sensitivity and specificity. Positron emission to-
mography (PET) meets these requirements to a large extent. PET is 
one of the most advanced molecular imaging methods, and it en-
ables the detection of tissue alterations on a molecular level before 
the alterations evolve into functional and, later, morphological dis-
orders (1–3). When performing diagnostics with PET, the patient is 
administered with a pharmaceutical that is labeled with a radioac-
tive isotope that emits positrons (e.g., 18F). Positrons thermalize (lose 
energy) in the tissue and annihilate with electrons, predominantly 
into two photons. These photons are registered using the PET scan-
ner and are used for the reconstruction of the image for the density 
distribution of the annihilation points. This distribution is correlated 
with the metabolism rate of the administered pharmaceutical; this 
information is used to determine locations of regions with an al-
tered metabolic activity.
Recent developments in total-body PET systems (4–7) have sig-
nificantly enhanced the PET diagnostic specificity to disentangle 
cancerous, inflamed, and infected tissues (8, 9). This is achieved by 
simultaneously enabling a dynamic metabolic rate and kinetic para-
metric imaging of all the organs, tissues, and cells throughout the 
human body (10, 11). However, there is still a scope for the quanti-
tative improvement of the PET diagnosis specificity for the disease 
assessment. This is because the photons that originate from the de-
cay of the radioisotopes and the annihilation of the positron with an 
electron in the cells can carry more information about the molecu-
lar environment than used in the PET diagnostics that are current-
ly being used. The state-of-the-art PET systems (12) [including 
uEXPLORER, the first total-body PET (13)] use only the informa-
tion about the location of the positron-electron annihilation and are 
insensitive to the processes that influence the positron annihilation 
inside the molecules, which may provide information about the al-
teration of the tissues at the molecular level (14). In the tissue, 
positron-electron annihilation may proceed directly (e+e− → photons) 
or via the formation of the intermediate positron-electron–bound 
state, referred to as a positronium (e+e− → positronium → photons). 
During PET scanning, almost 40% of the positron annihilations oc-
cur through the formation of positronium (15, 16), which may be 
formed in human tissues in the intra- and intermolecular spaces. 
Hence, positronium has not been used for medical diagnostics.
The positronium is unstable and decays into photons. In 25% of 
the cases, a short-lived parapositronium is formed, and in 75% of 
the cases, an orthopositronium (o-Ps) is formed. Parapositronium 
decays in vacuum predominantly into two photons, and o-Ps de-
cays into three photons, with the mean lifetimes of these states in 
vacuum equal to 125 ps and 142 ns, respectively (17). In the medium, 
the mean lifetime of o-Ps is shortened significantly. This is because, in 
addition to the self-annihilation of o-Ps, additional processes occur, 
e.g., annihilation of a positron from o-Ps with an electron from the 
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surrounding molecule (pickoff process) or interaction of o-Ps with 
oxygen or other biomolecules leading to the conversion of o-Ps to 
parapositronium and its subsequent self-annihilation into two pho-
tons. The mean lifetime of o-Ps in a patient’s body varies from ap-
proximately 1.8 ns in water molecules to approximately 4 ns in skin 
cells (18). Because of the pickoff and conversion processes, the 
mean lifetime of o-Ps is highly sensitive to the size of inter- and 
intramolecular voids (free volume between the atoms) and to the 
concentration of biomolecules in them. As a result, it can provide 
information about the disease progression in an initial stage (14). 
Several studies have investigated the changes of the positronium 
properties during dynamic processes while applying model and living 
biological systems (19–32). It has been found that there are differ-
ences in the positronium mean lifetimes and the production probabil-
ities in healthy and cancerous tissues, indicating that these parameters 
can be used as indicators for in vivo cancer classification. To exploit 
these environmentally modified properties of positronium as diag-
nostic biomarkers for conducting an in vivo tissue pathology assess-
ment, the properties of the positronium atoms need to be determined 
in a spatially resolved manner (1, 14, 33). The novel concept of this 
method, called positronium imaging (33, 34), and feasibility studies 
based on computer simulations have been reported in our recent 
publications (37, 38). This article presents the experimental imple-
mentation of the method and the first-ever positronium mean life-
time image, which was determined simultaneously with a standard 
PET image, using a specially designed PET scanner that overcomes 
the limitations of the state-of-the-art PET system. The scanner, which 
is referred to as the Jagiellonian PET (J-PET), was constructed and 
made operational at the Jagiellonian University in Poland (35, 36, 39–43). 
As an example of the application of the positronium imaging method, 
this study presents a positronium image that was determined for a 
phantom comprising cardiac myxoma and adipose tissue from 
patients (bioethical consent number 1072.6120.123.2017).
RESULTS
Positronium detection by the J-PET detector
Figure 1 displays the main results from this study, which include the 
positronium mean lifetime image and the image analog to the stan-
dardized uptake value (SUV). It should be stressed that, in this 
Fig. 1. The measurement scheme and the determined SUV and positronium images. The top left panel illustrates a part of a hemoglobin molecule with super-
imposed schemes, indicating decays of o-Ps (green circles) and parapositronium (p-Ps) (violet circle). o-Ps may undergo self-annihilation (pink arrows), pickoff process 
(gray arrows), or conversion to parapositronium, e.g., by interacting with oxygen molecule (green arrows). The top right panel shows the first part of the experimental 
workflow. Four samples from two patients were collected and divided into two classes: cardiac myxoma and adipose tissue. Each sample was inserted into a holder with 
the radioactive 22Na source, which was inserted into the J-PET detector. The blue and yellow circles show the locations of the samples during the measurement. Methods 
to reconstruct the image analogs to that of the SUV image (annihilation rate distribution) and positronium lifetime image are described in Methods. Reconstructed mean 
o-Ps lifetime in cardiac myxoma (1.9 ns) differs from the mean o-Ps lifetime in adipose tissue (2.6 ns). More comprehensive studies confirming the differences in the o-Ps 
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study, the annihilation rate is determined by the activity of the ap-
plied 22Na radionuclide and not by the pharmaceutical uptake rate 
as it is in the in vivo PET imaging. Both of these images were 
obtained simultaneously for the phantom, which comprised tissues 
that were operated from two patients (indicated as 1 and 2 in the 
J-PET tomography chamber). The imaged phantom consisted of 
four samples inserted into the J-PET tomograph. Two samples con-
sisted of cardiac myxoma tissue (indicated as blue circles), and the 
other two consisted of adipose tissue (indicated as yellow circles).
22Na isotope was used as a source of positrons. In addition to 
emitting the positrons, this isotope emits a prompt gamma ray with 
an energy of 1.27 MeV via the following reaction chain (Fig. 2): 
22Na → 22Ne* + e+ + v → 22Ne + (1.27 MeV) + e+ + . The source was 
surrounded by tissues and closed in the aluminum holder that was 
placed in the tomography chamber. The positrons that were emit-
ted from the source penetrated the tissue to a depth of about 1 mm 
(45) and annihilated with the electrons from the molecules that 
constitute the cells (Fig. 2). In about 40% of the cases, annihilation 
proceeds by formation of the positronium atoms, which are trapped 
in the intramolecular spaces (Fig. 1) (14). Seventy-five percent of 
the positronium atoms are produced as long-lived o-Ps. o-Ps has a 
lifetime that is very sensitive to the size of the voids and the concen-
tration in them of molecules such as oxygen molecules (19, 20). In 
the intramolecular voids of the tissue (as illustrated in the top left 
panel of Fig. 1), the o-Ps annihilates about 70 times more often via 
the pickoff and conversion processes and then via self-annihilation. 
Therefore, as a result of the o-Ps annihilation in the tissue, the emis-
sion of two photons is about 70 times more likely than the emission 
of three photons (37, 38, 46–48). Therefore, for the first demonstra-
tion of the positronium imaging, this study selected triple coinci-
dence events corresponding to the registration of two annihilation 
photons and one prompt gamma. The time and position of the 
interaction of the annihilation photons in the plastic strips of the 
J-PET tomograph were used to reconstruct the position and time of 
the annihilation (Figs. 2 and 3). Meanwhile, the time and position of 
the interaction of the prompt gamma were used to reconstruct the 
emission time of the prompt gamma. Because of the short time of 
the positron thermalization [in the order of 10 ps (49)] and a short 
time of 22Ne deexcitation [on average, it is about 3 ps (50)], the time 
of the prompt gamma emission is within tens of picoseconds 
equivalent to the time of the positron emission and the time of the 
positronium formation.
Positronium imaging
The reconstructed density distribution of the position of the annihi-
lation points (Fig. 1) constitutes the image of the annihilation rate 
[an analog of the standard uptake value (SUV image)]. In the studied 
case, it reflects the geometrical configuration of the tissues in the 
tomographic chamber (four samples are set at the vertices of the 
square) and the activity of the applied 22Na sources (for details, please 
see Table 1). For each voxel of the SUV image, a distribution of (t) 
the difference between the annihilation time and the time of the 
positron emission was determined. Each t distribution was fitted 
using the dedicated PALS Avalanche program (51, 52) to determine 
the mean lifetime for the o-Ps on a voxel-by-voxel basis. An image 
for the mean lifetime of o-Ps is shown in Fig. 1. It indicates that the 
mean lifetime of the o-Ps in cardiac myxoma is approximately 1.9 ns, 
and it differs significantly from the mean lifetime of the o-Ps in 
adipose tissues, which is approximately 2.6 ns.
The SUV and positronium images presented in Fig.  1 were 
reconstructed on the basis of the data that were collected with the 
J-PET tomograph (this is described in detail in Methods). The 
J-PET tomograph consists of 192 plastic scintillator strips (covered in 
a light- tight black foil that is visible in the photograph), and it is 
arranged into three concentric layers, as it is visualized by super-
imposed rings from the blue rectangles. Each scintillator is read out 
by the photomultipliers that are optically connected at the ends 
(39). The signals from the photomultipliers are sampled in the volt-
age domain by the newly developed programmable electronics (41). 
The data were collected with the continuous readout mode (43), 
and the filtration of events was performed off-line with a specialized 
software program (53).
DISCUSSION
The mean o-Ps lifetime image shown in Fig. 1 corresponds to the 
first-ever positronium image. It was determined using the J-PET 
tomograph. By overcoming the limitations of the current PET 
Fig. 2. Experiment workflow. The 22Na radionuclide emitting positron and prompt gamma is used as a source of positrons. They can annihilate with the electrons from 
the molecules of the cell. The annihilation photons and prompt gamma interact in the scintillator strips (blue rectangles) of the J-PET detector; this results in the produc-
tion of signals that are sampled by the front-end electronics (41), digitized, and collected by a data acquisition (DAQ) system (43). A single event of interest comprises the 
information of the position and time (xi, yi, zi, ti) for each registered photon. The events, in which the detector registers two annihilation photons and one prompt gamma, 
are selected for further analysis. The reconstructed positions of the annihilation photons, (x1,y1,z1) and (x2,y2,z2), enable the reconstruction of the so-called line of response 
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systems, it demonstrates the possibility of simultaneously achieving 
PET SUV imaging and positronium imaging using the PET 
detectors. The presented results also demonstrate the potential of 
positronium imaging in enhancing the specificity in the PET diag-
nostics. Visible and significant differences between the o-Ps lifetime 
in cancer and healthy tissues are observed, as shown in the example 
of the cardiac myxoma and adipose tissues. The observed difference 
in the mean lifetime of o-Ps in cardiac myxoma and adipose tissue 
is equal to about 700 ps, while the differences due to the changes of 
the concentration of molecules are expected at the level of less than 
10 ps as demonstrated for the case of oxygen molecules in the recent 
article [equation 9 in (20)]. Thus, we may assume that the observed 
difference will also remain significant under the in vivo conditions, 
although the concentration of biomolecules differs between dead 
and alive cells. The comprehensive studies of these phenomena 
will have to be carried out to answer of how to interpret changes in 
the positronium image in individual organs or tissue types.
The time-of-flight resolution of the constructed J-PET prototype 
amounts to 460 ps [full width at half maximum (FWHM) for the 
coincidence resolving time (CRT)] and corresponds to the spatial 
resolution of 6.9 cm (FWHM) in the image. Therefore, for the first 
images that were presented in this article, we used a rather large 
voxel size of 2  cm  by  2  cm  by  2  cm. However, the continuous 
advancement of the time resolution for the PET scanners (54–57) 
has promising perspectives to improve this resolution in the future. 
The best current clinical PET systems can achieve a time resolution 
of 210 ps (58), and the laboratory systems reach the CRT in 30 ps 
(59). This could result in a further improvement, even up to 10 ps 
(54, 55, 57); thus, it could create positronium images with a spatial 
resolution of 0.15 cm. The sensitivity for the positronium imaging 
of the constructed J-PET demonstrator is only 0.0016%. However, 
the advent of the total body PET systems and, in particular, the 
J-PET total-body PET system (1) can enhance the sensitivity for total 
body positronium imaging, such that it will be more than double in 
comparison to 2 PET imaging, corresponding to the current PET 
scanners that have a 20-cm axial field of view (1). For the CRT of 
about 500 ps, as presently achieved by the uEXPLORER total- body 
PET, the point spread function of the positronium image would equal 
to 30 mm (radial) and 7 mm (axial) (38).
Last, it is important to stress that the information that is com-
prised in the positronium images concerns the size of inter- and 
intramolecular voids and the concentration in them of molecules, 
e.g., oxygen molecules. Therefore, it is qualitatively different from 
the anatomical and morphological images that are obtained by com-
puted tomography and magnetic resonance imaging. It is also qual-
itatively different from the metabolic rate images that are obtained 
with the current PET systems. Therefore, when using positron im-
aging in clinical practice, the specificity of PET diagnostics in dis-
ease assessment will increase. However, establishing the quantitative 
correlations between the positronium properties in the tissue and 
the type and degree of tissue pathology still requires further 
research (1, 14).
Fig. 3. Analysis of the experiment. Experiment conducted as in Fig. 2 was analyzed by the following procedure. The distribution of the reconstructed positions of the 
annihilations constitutes the SUV image [a pictorial example of this image is shown in (left)]. The photons resulting from the deexcitation of the 22Ne* can be used to 
calculate the positron annihilation lifetime (t) distribution for every voxel in the SUV image. The decomposition of the t distribution [an example distribution for cardi-
ac myxoma tissue is shown in (middle)] allows us to distinguish components coming from the parapositronium (light green dashed line) and o-Ps (dark blue dashed line). 
It also distinguishes processes such as direct annihilation of the positron and the electron without producing positronium (direct; turquoise line) and from the annihila-
tions in the source material (source; red dashed line). In addition, the signal from accidental coincidences is visible (background; violet line). The positronium image 
[shown pictorially in (right)] has each voxel filled with the value of the mean o-Ps lifetime, and it is obtained from the decomposition of the t distribution.
Table 1. Geometry and activity of the phantom. The positions of the 
imaged samples and the activity of the applied 22Na sources are listed in 
the second and third columns, respectively. The fourth column indicates 
number of events in a given spectrum fulfilling all the selection criteria 
described in the text. In total, out of about 107 collected three-hit events, 
only 232,357 events were used in the lifetime spectra shown in Fig. 5. The 
activity of the source, which is normalized to the total number of counts, 
is given in the last column. It shows that the reconstructed intensity in the 
SUV image, shown in Fig. 1, is in good agreement with the expectations 
that are based on the activity of the used 22Na sources. 
Sample
Position X, 












myxoma 1 −8.1, 8.1, 0 0.345 65 636 0.988
Cardiac 
myxoma 2 −8.1, −8.1, 0 0.238 45 493 0.993
Adipose 
tissue 1 8.1, 8.1, 0 0.393 76 651 1.013
Adipose 
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The method can be also applied to the regular PET system 
based on crystal scintillators. Note that crystal-based PET systems 
with an axial field of view of 60 cm may achieve sensitivity for 
positronium imaging comparable to the standard 2 PET imaging 
with 20-cm-long PET scanners (1). New commercial tomographs 
offered [and already installed in clinics, e.g., by Siemens (60) or 




A 22Na radionuclide was used as a positron source. 22Na undergoes 
+ decay by emitting an electron neutrino (e) and a positron (e+), 
which can annihilate with an electron (e−) that comes from the cell 
(Fig. 2, yellow), thus resulting in the emission of two photons with 
an energy of 511 keV that are emitted in the opposite directions. 
After the + emission, 22Na is transformed to the excited state of the 
22Ne* isotope, which then deexcitates with the emission of a prompt 
gamma ray with an energy of 1275 keV. The emitted photons can be 
registered by the J-PET detector when they deposit the energy in 
scintillators (blue rectangles in Fig. 2) through the Compton effect.
Preparation of the samples and the setup
The samples of the cardiac myxoma and adipose tissue were ex-
tracted from two patients from the John Paul II Hospital in Kraków 
(bioethical consent number 1072.6120.123.2017). After transporta-
tion to the Faculty of Physics, Astronomy, and Applied Computer 
Science of the Jagiellonian University, the samples were fixed in 
10% formalin. Every fixed sample was cut into two pieces to cover 
the 22Na source from both sides, as shown in Fig. 1. The samples 
with radioactive sources were inserted into plastic chambers and 
placed on a Kapton scaffolding in the J-PET detector, equidistant 
from the center, as shown in Fig. 1. The activities of the applied 22Na 
sources are listed in Table 1.
J-PET detector
The J-PET detector photograph is shown in Fig. 1, and transversal 
cross section is shown schematically in Fig. 2. It is constructed using 
192 plastic scintillator strips that are arranged in three cylindrical 
and concentric layers. These include the first layer, which has 
48 scintillators and is 42.5 cm away from the center; the second layer, 
which has 48 scintillators and is 46.75 cm away from the center; and 
the third layer, which has 96 scintillators and is 57.5 cm away from 
the center. EJ-230 plastic scintillators with dimensions of 7 mm by 
Fig. 4. Event selection procedure. The top left panel (A) represents the distribution of the multiplicity of the hits. In this analysis, only the events with three hits (signals 
registered in three scintillator strips) were taken into account. The top middle panel (B) describes the signal sampling method. The dots represent the crossing of signals 
with the preset voltage threshold. Each dot corresponds to the measurement of the time (time stamp) that is digitized and collected by the electronic readouts and DAQ 
system. The area of the signal is approximated by the weighted mean of the TOT values. In the analysis, as the TOT characterizes the energy loss (62), the sum of the TOT 
values measured at both sides (side A and B) of the scintillator strip is used. The top right panel (C) represents the TOT distribution. The Compton edges for 511- and 1275-keV 
photons are visible at 18 and 33 ns, respectively. The red and gray regions indicate the TOT range used for the identification of the annihilation and prompt photons, 
respectively. (D and E) The example of possible background events where one of the annihilation photons was not registered; instead, another annihilation photon (D) 
(dashed red arrow) or a prompt photon (E) (solid black arrow) was scattered twice. The bottom left panel (F) shows the distribution of tij for a given pair of hits (i,j). The 
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19 mm by 500 mm are used as an active part of the detector (Eljen 
Technology, https://eljentechnology.com/). Both ends of the long 
axis of the scintillator were connected to the vacuum photomulti-
pliers, which form a single detection module (35, 39, 42). The light 
that is generated in the scintillators is converted to electric signals 
using the Hamamatsu R9800 vacuum photomultipliers (Hamamatsu, 
https://www.hamamatsu.com/us/en/index.html). The electric signals 
from the photomultipliers are probed at four thresholds using 
dedicated front-end electronics (42) and converted to the binary 
data by the novel trigger-less data acquisition (DAQ) system (43).
Fig. 5. Positron annihilation lifetime spectra. The middle panel shows the SUV image (as in Fig. 1) in the range from −30 to 30 cm. On the left and right sides of the SUV 
image, the exemplary positron lifetime spectra (t) are shown for the regions that are marked as blue and yellow circles. The positron annihilation components were es-
timated by fitting these spectra with the PALS Avalanche software program (51, 52), which is dedicated for the J-PET detector. The exponential tail is similar for the sam-
ples on the right (o-Ps crossing background line near 12 ns) and on the left (o-Ps crossing the background line near 10 ns) separately. The model function is given by 
Fit(t), which is a convolution of the exponential and Gaussian functions. Fits are in a very good agreement with the data confirmed by the values of the resulting adjusted 
R2 = 0.999 for all of the fits and reduced 2 values: (top left) 0.999, (bottom left) 1.067, (top right) 1.039, and (bottom right) 1.253. The resulting fitted parameters of each 
component for each sample are shown in Table 2. The amplitudes of the individual components for the same type of the samples (myxoma or adipose) differ by only 7% 
relative value. The mean o-Ps lifetimes for the cardiac myxoma samples are equal to (top left) 1.950 (19) ns and (bottom left) 1.874 (20) ns with an intensity of (top left) 
21.39 (47)% and (bottom left) 23.27 (45)%. For the adipose tissue, the mean o-Ps lifetimes are equal to (top right) 2.645 (27) ns and (bottom right) 2.581 (30) ns with an 
intensity of (top right) 21.49 (41)% and (bottom right) 21.56 (54)%.
Table 2. Results from fitting PAL spectra for each sample position shown in Fig. 5.  Parapositronium and direct annihilation mean lifetimes were fixed to 
values of 0.125 and 0.388 ns, respectively. This resulted in more stable results for fitting the mean lifetime of o-Ps, the only parameter of interest. o-Ps mean 
lifetime was higher for adipose tissue for both samples. Parapositronium and direct annihilation intensities were in agreement for the same type of the sample, 
cardiac myxoma or adipose tissue. Values of the o-Ps mean lifetime was very close for a given type of the sample. Fitted models were in good agreement with 
the data indicated by adjusted R2 and reduced 2 values close to 1. 
Parameter name Cardiac myxoma 1 Cardiac myxoma 2 Adipose tissue 1 Adipose tissue 2
Parapositronium mean 
lifetime (ns) 0.125 (fixed)
Parapositronium intensity (%) 13.26 (18) 12.21 (21) 17.18 (16) 17.14 (20)
Direct annihilation mean 
lifetime (ns) 0.388 (fixed)
Direct annihilation intensity (%) 65.35 (22) 64.52 (27) 61.34 (20) 61.31 (23)
o-Ps mean lifetime (ns) 1.950 (19) 1.874 (20) 2.645 (27) 2.581 (30)
o-Ps intensity (%) 21.39 (47) 23.27 (45) 21.49 (41) 21.56 (54)
Adjusted R2 0.999 0.999 0.999 0.999
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Framework and analysis procedure
The data collected using the J-PET detector were analyzed using a 
specialized software program called the J-PET Framework (53), 
which is based on the C++ architecture. The analysis was performed 
in several steps: reconstructing the signals, reconstructing the hits, 
creating events, and the final event-by-event analysis. The DAQ 
system collects the times when the electric signal produced in the 
photomultiplier crosses the system thresholds. The signal is recon-
structed when it passes one or more thresholds in a given time win-
dow (23 ns) for a given photomultiplier. A hit is generated from a 
pair of signals that come from two different photomultipliers con-
nected to the same scintillator in a time window of 5 ns. Last, an 
event is a set of hits that are registered within a time window of 200 ns. 
A distribution of the hit multiplicity during an event is shown 
in Fig. 4A.
When reconstructing the positronium image, the signals from 
two annihilation photons and a prompt photon are required. There-
fore, in this analysis, only events with three registered hits were taken 
into account. The origin of the hits was chosen on the basis of the 
time-over-threshold (TOT) value, which is an estimate of the de-
posited energy in a scintillator (62). The TOT value was calculated 
as the weighted mean of the widths of the signals for four different 
thresholds, in which the weights were selected on the basis of the 
difference between two consecutive thresholds as shown in Fig. 4B. 
The TOT distribution can be seen in Fig. 4C. The red area indicates 
the energy deposition that is close to the Compton edge that corre-
sponds to the 511-keV photon that comes from the positron-electron 
annihilation, and the black area represents 1275-keV photons from 
the deexcitation of the source. For the selected events that contain 
two annihilation hits, the geometry condition is checked (the angle 
between two annihilation hits), so that the annihilation potentially 
occurs from the interior of the J-PET detector. All the potential 
scatterings between the neighboring scintillators were suppressed 
by the additional geometrical condition in which the angle between 
the prompt gamma and the annihilation photon hit positions is larger 
than 15°. In general, the events are filtered to suppress the scatter-
ings and other sources of the background by applying the interac-
tion time, energy deposition, and geometrical relations between the 
positions of the interactions. The main source of background is formed 
because of the misidentification of the signals from the photons 
scattered in the detector as signals from the annihilation photons. 
An example of the background events is presented in Fig. 4 (D and E). 
This background is suppressed by testing whether the difference be-
tween the times of the two hits is equal to the time required by light 
to travel the distance between these hit positions. The distribution 
of this defined test parameter t is shown in Fig. 4F. If the hits cor-
respond to the scattered photon, then the value of t is close to zero. 
Therefore, the events with t > −1 ns are rejected.
From the selected events, the annihilation position is recon-
structed, and the SUV image is created. For each voxel in the SUV 
image, the positron annihilation lifetime distribution is determined, 
in which the mean o-Ps lifetime is extracted by the PALS Avalanche 
software program (51, 52). As an example, four positron annihila-
tion lifetime spectra from four areas that correspond to the four 
different samples are shown in Fig. 5.
PALS Avalanche
A dedicated software program for the positron lifetime analysis 
(51, 52) that is compatible with the J-PET Framework software 
program allows the positron lifetime spectrum to be decomposed 
into different components. This software was written in C++, and it 
is based on the ROOT libraries (63). The PALS Avalanche software 
program enables the fitting of the multiexponential distribution, 
which is smeared with a linear combination of the Gaussians [Fit(t) 
formula given in Fig. 4]. The decomposition leads to the extraction 
of the mean o-Ps lifetime in a given voxel. The influence of the Kapton 
foil that covers each source was estimated as the 10% intense com-
ponent with a mean lifetime of 0.374 ns. The parapositronium mean 
lifetime was fixed to a value of 0.125 ns. Since the only parameter of 
interest was the mean lifetime of o-Ps, it can yield more stable 
results of the fitting. The resolution function was estimated as a 
single Gaussian with a  value of 0.266 ns, which corresponds to a 
time resolution for a single measured time of 0.154 ns. The resulting 
parameters of each component are shown in Table 2.
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